Clincosm LogoSign in Get a demo

Alzheimer Disease

Showing NaN - NaN of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer, Dementia, Mixed, Dementia Trial in Toronto (Transcranial Direct Current Stimulation (tDCS))

Recruiting
  • Alzheimer Disease
  • +4 more
  • Transcranial Direct Current Stimulation (tDCS)
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Nov 12, 2021

Alzheimer Trial in Toronto (Blood Brain Barrier (BBB) Disruption)

Recruiting
  • Alzheimer Disease
  • Blood Brain Barrier (BBB) Disruption
  • Toronto, Ontario, Canada
    Division of Neurosurgery, Sunnybrook Health Sciences Centre
Oct 8, 2021

Alzheimer Trial in Canada, United States (Simufilam 100 mg oral tablet, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Simufilam 100 mg oral tablet
  • Placebo
  • Gilbert, Arizona
  • +16 more
Sep 27, 2021

MDD, Alzheimer, Mild Cognitive Impairment Trial in Toronto (Brainsway H1-Coil Deep TMS System)

Recruiting
  • Major Depressive Disorder
  • +2 more
  • Brainsway H1-Coil Deep TMS System
  • Toronto, Ontario, Canada
    Rotman Research Institute at Baycrest
Sep 14, 2021

Neuro-Degenerative Disease, Dementia, Caregiver Burnout Trial in Toronto (Educational Brochure)

Enrolling by invitation
  • Neuro-Degenerative Disease
  • +6 more
  • Educational Brochure
  • Toronto, Ontario, Canada
    Toronto Western Hospital, University Health Network
Apr 26, 2021

Alzheimer Trial in Canada, United States (DBS-f on, DBS-f off)

Completed
Has Results
  • Alzheimer Disease
  • DBS-f on
  • DBS-f off
  • Phoenix, Arizona
  • +6 more
Aug 21, 2020

Alzheimer Trial in Canada, United States (Flortaucipir F18, Brain PET Scan)

Completed
Has Results
  • Alzheimer Disease
  • Flortaucipir F18
  • Brain PET Scan
  • San Diego, California
  • +9 more
Aug 7, 2020

Alzheimer, Agitation, Weight Loss Trial in Toronto (Nabilone, Placebo)

Completed
  • Alzheimer Disease
  • +4 more
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Jun 23, 2020

Alzheimer Trial in Canada, United States (Placebo Control, ELND005)

Completed
Has Results
  • Alzheimer Disease
  • Phoenix, Arizona
  • +61 more
Oct 17, 2019

Alzheimer Trial in Toronto (MHRC)

Unknown status
  • Alzheimer Disease
  • MHRC
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Sep 26, 2019

Alzheimer Trial in Toronto (Bilateral fornix DBS implantation,)

Completed
  • Alzheimer Disease
  • Bilateral fornix DBS implantation,
  • Toronto, Ontario, Canada
    Toronto Western Hospital
Sep 25, 2019

The Ontario Neurodegenerative Disease Research Initiative

Completed
  • Alzheimer Disease
  • +4 more
  • Observational Cohort
  • Hamilton, Ontario, Canada
  • +11 more
Sep 23, 2019

Alzheimer Trial in Worldwide (BI 409306, Placebo)

Completed
Has Results
  • Alzheimer Disease
  • BI 409306
  • Placebo
  • Orange, California
  • +51 more
Oct 31, 2018

Alzheimer Trial in Toronto (BBB opening)

Completed
  • Alzheimer Disease
  • BBB opening
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Jun 13, 2018

Dementia, Alzheimer Trial in Toronto (Dextroamphetamine, Methylphenidate)

Completed
  • Dementia
  • Alzheimer Disease
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Apr 26, 2017

Hearing Instruments in Alzheimer's Disease

Completed
  • Alzheimer Disease
  • Hearing Loss
  • Standard audiologic rehabilitation (incl. HI)
  • Toronto, Ontario, Canada
    Baycrest Center of Geriatric Care
Apr 10, 2017

Alzheimer Trial in Worldwide (bapineuzumab, )

Terminated
Has Results
  • Alzheimer Disease
  • Birmingham, Alabama
  • +347 more
Dec 4, 2015

Alzheimer Trial in Worldwide (AZD3480, Donepezil)

Completed
  • Alzheimer Disease
  • Graz, Osterreich, Austria
  • +70 more
Jul 22, 2014

Alzheimer Trial in Worldwide (Rivastigmine 5 cm^2, Rivastigmine 10 cm^2, Rivastigmine 15 cm^2)

Completed
Has Results
  • Alzheimer Disease
  • Rivastigmine 5 cm^2
  • +4 more
  • Birmingham, Alabama
  • +144 more
Sep 17, 2012

Down Syndrome, Alzheimer Trial in Worldwide (Vitamin E, multivitamin, Placebo)

Unknown status
  • Down Syndrome
  • Alzheimer Disease
  • Vitamin E
  • +2 more
  • Farmington, Connecticut
  • +21 more
May 2, 2012

Alzheimer Trial in Toronto (Far Infrared Radiation (5µm to 20µm wavelength))

Unknown status
  • Alzheimer Disease
  • Far Infrared Radiation (5μm to 20μm wavelength)
  • Toronto, Ontario, Canada
    The Centre for Incurable Diseases
Aug 14, 2009

Alzheimer Trial in Canada, United States (xaliproden (SR57746A))

Completed
  • Alzheimer Disease
  • xaliproden (SR57746A)
  • Birmingham, Alabama
  • +120 more
Aug 20, 2008

Alzheimer, Dementia Trial in Worldwide (MPC-7869)

Terminated
  • Alzheimer Disease
  • Dementia
  • Phoenix, Arizona
  • +91 more
Aug 1, 2008

Alzheimer Trial in Canada, United States (3APS)

Unknown status
  • Alzheimer Disease
  • Peoria, Arizona
  • +66 more
Feb 27, 2007